{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:27:06Z","timestamp":1784075226820,"version":"3.55.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000179","name":"Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["5R21NS094131-02"],"award-info":[{"award-number":["5R21NS094131-02"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1U01NS102135-01A1"],"award-info":[{"award-number":["1U01NS102135-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.nbd.2019.02.017","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T23:16:41Z","timestamp":1550791001000},"page":"104406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy"],"prefix":"10.1016","volume":"133","author":[{"given":"Vassiliki","family":"Aroniadou-Anderjaska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiza H.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Apland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.02.017_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.conb.2014.08.016","article-title":"Interneuron control of hippocampal oscillations","volume":"31","author":"Allen","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0010","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuroscience.2008.11.053","article-title":"Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro","volume":"159","author":"Apland","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2019.02.017_bb0015","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuro.2010.05.014","article-title":"Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology","volume":"31","author":"Apland","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.112.198689","article-title":"Efficacy of the GluK1\/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration","volume":"344","author":"Apland","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2019.02.017_bb0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.114.217299","article-title":"The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302","volume":"351","author":"Apland","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2019.02.017_bb0030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s12640-017-9789-7","article-title":"Susceptibility to soman toxicity and efficacy of LY293558 against soman-induced seizures and neuropathology in 10-month-old male rats","volume":"32","author":"Apland","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2019.02.017_bb0035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12640-018-9907-1","article-title":"Full protection against soman-induced seizures and brain damage by LY293558 and caramiphen combination treatment in adult rats","volume":"34","author":"Apland","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2019.02.017_bb0040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.117.245969","article-title":"Comparing the antiseizure and neuroprotective efficacy of LY293558, diazepam, caramiphen, and LY293558-caramiphen combination against soman in a rat model relevant to the pediatric population","volume":"365","author":"Apland","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2019.02.017_bb0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1469-8749.1995.tb15014.x","article-title":"Lorazepam versus diazepam in the treatment of epileptic seizures and status epilepticus","volume":"37","author":"Appleton","year":"1995","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00726-006-0415-x","article-title":"Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders","volume":"32","author":"Aroniadou-Anderjaska","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.nbd.2019.02.017_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.eplepsyres.2007.11.011","article-title":"Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy","volume":"78","author":"Aroniadou-Anderjaska","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2019.02.017_bb0060","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.neuro.2009.06.011","article-title":"Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus","volume":"30","author":"Aroniadou-Anderjaska","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2012.07.006","article-title":"Presynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors","volume":"221","author":"Aroniadou-Anderjaska","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2019.02.017_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/nyas.13028","article-title":"Long-term neuropathological and behavioral impairments after exposure to nerve agents","volume":"1374","author":"Aroniadou-Anderjaska","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2018.01.021","article-title":"Oscillatory synchronous inhibition in the basolateral amygdala and its primary dependence on NR2A-containing NMDA receptors","volume":"373","author":"Aroniadou-Anderjaska","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2019.02.017_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fncel.2012.00035","article-title":"Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!","volume":"6","author":"Ben-Ari","year":"2012","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Ben-Ari","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.nbd.2019.02.017_bb0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0896-6273(90)90213-Y","article-title":"Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development","volume":"5","author":"Bettler","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.02.017_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neulet.2009.02.035","article-title":"Age dependent mortality in the pilocarpine model of status epilepticus","volume":"453","author":"Blair","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2019.02.017_bb0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0026-895X(25)08763-2","article-title":"Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid","volume":"49","author":"Bleakman","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1523\/JNEUROSCI.23-02-00442.2003","article-title":"Bidirectional modulation of GABA release by presynaptic glutamate receptor 5 kainate receptors in the basolateral amygdala","volume":"23","author":"Braga","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0110","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.bjp.0706796","article-title":"Mechanism of action of benzodiazepines on GABAA receptors","volume":"148","author":"Campo-Soria","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0115","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2014.2625","article-title":"Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. Pediatric emergency care applied research network (PECARN)","volume":"311","author":"Chamberlain","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.nbd.2019.02.017_bb0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuro.2015.05.001","article-title":"Sarin-induced brain damage in rats is attenuated by delayed administration of midazolam","volume":"49","author":"Chapman","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/0972-2327.56312","article-title":"Status epilepticus","volume":"12","author":"Cherian","year":"2009","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0130","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/j.1476-5381.1995.tb15929.x","article-title":"Blockade by sigma site ligands of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones","volume":"116","author":"Church","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropharm.2008.06.063","article-title":"A nomenclature for ligand-gated ion channels","volume":"56","author":"Collingridge","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/2185","article-title":"GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells","volume":"1","author":"Cossart","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0145","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1528-1167.2009.02478.x","article-title":"Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats","volume":"51","author":"De Araujo Furtado","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0150","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1523\/JNEUROSCI.1848-10.2010","article-title":"The muscarinic long-term enhancement of NMDA and AMPA receptor-mediated transmission at Schaffer collateral synapses develop through different intracellular mechanisms","volume":"30","author":"de Sevilla","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0155","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1523\/JNEUROSCI.2723-07.2008","article-title":"Cholinergic-mediated IP3-receptor activation induces long-lasting synaptic enhancement in CA1 pyramidal neurons","volume":"28","author":"de Sevilla","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.12037","article-title":"Possible alterations in GABA(A) receptor signaling that underlie benzodiazepine-resistant seizures","volume":"53","author":"Deeb","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuro.2014.04.006","article-title":"Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication","volume":"44","author":"Deshpande","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0170","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neuro.2014.08.008","article-title":"Chronic behavioral and cognitive deficits in a rat survival model of paraoxon toxicity","volume":"44","author":"Deshpande","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0175","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.4103\/neuroindia.NI_958_16","article-title":"Status epilepticus: refractory and super-refractory","volume":"65","author":"Dubey","year":"2017","journal-title":"Neurol. India"},{"key":"10.1016\/j.nbd.2019.02.017_bb0180","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01427.x","article-title":"Neuroprotective efficacy of caramiphen against soman and mechanisms of its action","volume":"164","author":"Figueiredo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1124\/jpet.110.171835","article-title":"The GluK1 (GluR5) Kainate\/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology","volume":"336","author":"Figueiredo","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2019.02.017_bb0190","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1111\/j.1476-5381.1995.tb15928.x","article-title":"Blockade by sigma site ligands of N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons","volume":"116","author":"Fletcher","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.csbj.2015.03.004","article-title":"The role of excitotoxic programmed necrosis in acute brain injury","volume":"13","author":"Fujikawa","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.nbd.2019.02.017_bb0200","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1523\/JNEUROSCI.5663-11.2012","article-title":"Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding","volume":"32","author":"Gielen","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.taap.2005.03.007","article-title":"Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an electrographic, behavioral, and histological study in freely moving rats","volume":"209","author":"Gilat","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0210","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1067\/mcp.2000.108677","article-title":"Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid\/kainate antagonist LY293558 on spontaneous and evoked postoperative pain","volume":"68","author":"Gilron","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2019.02.017_bb0215","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1528-1157.2003.62402.x","article-title":"Diazepam terminates brief but not prolonged seizures in young, na\u00efve rats","volume":"44","author":"Goodkin","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0220","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0225","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1523\/JNEUROSCI.23-18-07069.2003","article-title":"Selective antagonism of GluR5 kainate receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons","volume":"23","author":"Gryder","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0230","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/jpet.104.065433","article-title":"A Guinea pig hippocampal slice model of organophosphate-induced seizure activity","volume":"310","author":"Harrison","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2019.02.017_bb0235","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1998.tb05110.x","article-title":"An overview of benzodiazepines in seizure management","volume":"39","author":"Henriksen","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0014-2999(93)90130-A","article-title":"Caramiphen, iodocaramiphen and nitrocaramiphen are potent, competitive, muscarinic M1 receptor-selective agents","volume":"231","author":"Hudkins","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0245","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1164\/rccm.201406-1150CI","article-title":"Respiratory complications of organophosphorus nerve agent and insecticide poisoning. Implications for respiratory and critical care","volume":"190","author":"Hulse","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.nbd.2019.02.017_bb0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuropharm.2008.08.023","article-title":"Kainate receptors: pharmacology, function and therapeutic potential","volume":"56","author":"Jane","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0255","first-page":"567","article-title":"Developmental aspects of NMDA receptor agonists and antagonists in the central nervous system","volume":"30","author":"Johnston","year":"1994","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.nbd.2019.02.017_bb0260","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2019.02.017_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nbd.2017.03.017","article-title":"Enhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus","volume":"103","author":"Joshi","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.02.017_bb0270","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nn.4251","article-title":"4-Hz oscillations synchronize prefrontal-amygdala circuits during fear behavior","volume":"19","author":"Karalis","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0275","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/cns.12353","article-title":"Depolarizing GABA and developmental epilepsies","volume":"21","author":"Khazipov","year":"2015","journal-title":"CNS Neurosci. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2019.02.017_bb0280","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/jat.811","article-title":"Combination anticonvulsant treatment of soman-induced seizures","volume":"21","author":"Koplovitz","year":"2001","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0285","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1152\/jn.00949.2009","article-title":"Central cholinesterase inhibition enhances glutamatergic synaptic transmission","volume":"103","author":"Kozhemyakin","year":"2010","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0290","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuroscience.2012.12.055","article-title":"Are morphologic and functional consequences of status epilepticus in infant rats progressive?","volume":"235","author":"Kubov\u00e1","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2019.02.017_bb0295","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0928-4257(99)80007-2","article-title":"Medical management of organophosphate-induced seizures","volume":"92","author":"Lallement","year":"1998","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.nbd.2019.02.017_bb0300","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.pbb.2011.09.011","article-title":"Characterizing the behavioral effects of nerve agent-induced seizure activity in rats: increased startle reactivity and perseverative behavior","volume":"100","author":"Langston","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2019.02.017_bb0305","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2014.10.035","article-title":"Caramiphen-induced block of sodium currents and spinal anesthesia","volume":"746","author":"Leung","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0310","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0028-3908(98)00109-9","article-title":"GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro","volume":"37","author":"Li","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0315","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/88432","article-title":"Kainate receptor-mediated heterosynaptic facilitation in the amygdala","volume":"4","author":"Li","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0320","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nn.3582","article-title":"Prefrontal entrainment of amygdala activity signals safety in learned fear and innate anxiety","volume":"17","author":"Likhtik","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0325","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","article-title":"NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo","volume":"27","author":"Liu","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0330","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.neuron.2012.03.021","article-title":"The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults","volume":"74","author":"Martel","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.02.017_bb0335","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2019.02.017_bb0340","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-8993(87)91593-9","article-title":"Direct microinjection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology","volume":"435","author":"McDonough","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.02.017_bb0345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in Guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0350","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.taap.2015.02.008","article-title":"A rat model of nerve agent exposure applicable to the pediatric population: the anticonvulsant efficacies of atropine and GluK1 antagonists","volume":"284","author":"Miller","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0355","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.116.236125","article-title":"The M1 muscarinic receptor antagonist VU0255035 delays the development of status epilepticus after organophosphate exposure and prevents hyperexcitability in the basolateral amygdala","volume":"360","author":"Miller","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2019.02.017_bb0360","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2004.03.005","article-title":"Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist","volume":"47","author":"More","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0365","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0370","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.02.017_bb0375","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/nyas.13147","article-title":"Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment","volume":"1378","author":"Niquet","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.02.017_bb0385","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/epi.13695","article-title":"Treatment of experimental status epilepticus with synergistic drug combinations","volume":"58","author":"Niquet","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0390","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-3-540-74806-9_16","article-title":"\"Midazolam and other benzodiazepines\". In Sch\u00fcttler J, Schwilden H. modern anesthetics","author":"Olkkola","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0395","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1523\/JNEUROSCI.4009-13.2014","article-title":"ASIC1a activation enhances inhibition in the basolateral amygdala and reduces anxiety","volume":"34","author":"Pidoplichko","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0400","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0920-1211(98)00055-2","article-title":"Amygdala damage in experimental and human temporal lobe epilepsy","volume":"32","author":"Pitkanen","year":"1998","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2019.02.017_bb0405","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G","article-title":"Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum","volume":"378","author":"Portera-Cailliau","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0410","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuro.2013.06.006","article-title":"Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure","volume":"38","author":"Prager","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0415","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuropharm.2014.01.035","article-title":"The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior","volume":"81","author":"Prager","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0420","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neuro.2014.08.007","article-title":"Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala","volume":"44","author":"Prager","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0425","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2014.08.014","article-title":"LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety","volume":"89","author":"Prager","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0430","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/epi.12266","article-title":"Receptor trafficking hypothesis revisited: plasticity of AMPA receptors during established status epilepticus","volume":"54","author":"Rajasekaran","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0435","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2202-15-47","article-title":"Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes","volume":"15","author":"RamaRao","year":"2014","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0440","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/archneur.1979.00500450029003","article-title":"Brain uptake of phenytoin, phenobarbital, and diazepam","volume":"36","author":"Ramsay","year":"1979","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0445","first-page":"551","article-title":"The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning","volume":"20","author":"Raveh","year":"1999","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0450","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/toxsci\/kfg166","article-title":"Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction","volume":"75","author":"Raveh","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0455","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.taap.2007.10.020","article-title":"Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen","volume":"227","author":"Raveh","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0460","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tox.2014.09.005","article-title":"Caramiphen edisylate: an optimal antidote against organophosphate poisoning","volume":"325","author":"Raveh","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0465","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/epi.12989","article-title":"Midazolam as an anticonvulsant antidote for organophosphate intoxication\u2014a pharmacotherapeutic appraisal","volume":"56","author":"Reddy","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0470","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1073\/pnas.97.3.1293","article-title":"Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons","volume":"97","author":"Rodriguez-Moreno","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0475","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/TME.0000000000000064","article-title":"Benzodiazepine selection in the management of status epilepticus: a review","volume":"37","author":"Rogalski","year":"2015","journal-title":"Adv. Emerg. Nurs. J."},{"key":"10.1016\/j.nbd.2019.02.017_bb0480","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0006-8993(97)00594-5","article-title":"Excitatory amino acid receptors in the basolateral amygdala regulate anxiety responses in the social interaction test","volume":"764","author":"Sajdyk","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.02.017_bb0485","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-2982.2004.00723.x","article-title":"LY293558, a novel AMPA\/GluR5 antagonist, is efficacious and well-tolerated in acute migraine","volume":"24","author":"Sang","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0490","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.taap.2012.01.017","article-title":"The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: synergism with the benzodiazepine diazepam","volume":"259","author":"Schultz","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0495","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ntt.2014.06.002","article-title":"Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats","volume":"44","author":"Schultz","year":"2014","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0500","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1749-6632.2003.tb07090.x","article-title":"The amygdala, panic disorder, and cardiovascular responses","volume":"985","author":"Shekhar","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0505","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0361-9230(90)90097-J","article-title":"Age-related differences in soman toxicity and in blood and brain regional cholinesterase activity","volume":"24","author":"Shih","year":"1990","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2019.02.017_bb0510","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0515","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0520","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/088307380201700203","article-title":"Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus","volume":"17","author":"Singhi","year":"2002","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0525","doi-asserted-by":"crossref","first-page":"12199","DOI":"10.1021\/jp307790v","article-title":"Aging mechanism of soman inhibited acetylcholinesterase","volume":"116","author":"Sirin","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.nbd.2019.02.017_bb0530","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12031-009-9253-0","article-title":"Protection against sarin-induced seizures in rats by direct brain microinjection of scopolamine, midazolam or MK-801","volume":"40","author":"Skovira","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0535","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nn880","article-title":"Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures","volume":"5","author":"Smolders","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0540","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nature07991","article-title":"Parvalbumin neurons and gamma rhythms enhance cortical circuit performance","volume":"459","author":"Sohal","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2019.02.017_bb0545","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.neuron.2013.09.033","article-title":"Inhibition-induced theta resonance in cortical circuits","volume":"80","author":"Stark","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.02.017_bb0550","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.neuron.2014.07.026","article-title":"Fear and safety engage competing patterns of theta-gamma coupling in the basolateral amygdala","volume":"83","author":"Stujenske","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.02.017_bb0555","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0701902","article-title":"The anticonvulsant actions of sigma receptor ligands in the Mg2+-free model of epileptiform activity in rat hippocampal slices","volume":"124","author":"Thurgur","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0560","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.eplepsyres.2012.04.014","article-title":"Characterization of status epilepticus induced by two organophosphates in rats","volume":"101","author":"Todorovic","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2019.02.017_bb0565","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ana.24967","article-title":"Phenobarbital and midazolam increase neonatal seizure-associated neuronal injury","volume":"82","author":"Torolira","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0570","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0074-7742(06)81007-X","article-title":"Epidemiology and outcomes of status epilepticus in the elderly","volume":"81","author":"Towne","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0575","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","article-title":"25 years of advances in the definition, classification and treatment of status epilepticus","volume":"44","author":"Trinka","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.nbd.2019.02.017_bb0580","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1528-1167.2005.49604.x","article-title":"Time-dependent effect of kainate-induced seizures on glutamate receptor GluR5, GluR6, and GluR7 mRNA and protein expression in rat hippocampus","volume":"46","author":"Ullal","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0585","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/pr.109.002063","article-title":"Regulation of GABA(A) receptor subunit expression by pharmacological agents","volume":"62","author":"Uusi-Oukari","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2019.02.017_bb0590","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1111\/ejn.12756","article-title":"Persistent reduction of hippocampal glutamine synthetase expression after status epilepticus in immature rats","volume":"40","author":"van der Hel","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0595","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0028-3908(98)00148-8","article-title":"The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus","volume":"37","author":"Vignes","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2019.02.017_bb0600","article-title":"Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA(A) receptor modulators?","volume":"2012","author":"Vinkers","year":"2012","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0605","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainresbull.2012.10.005","article-title":"Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects","volume":"93","author":"Vizi","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2019.02.017_bb0610","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-8993(91)90235-N","article-title":"Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam","volume":"553","author":"Walton","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.02.017_bb0615","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/epi.12285","article-title":"Trafficking of NMDA receptors during status epilepticus: therapeutic implications","volume":"54","author":"Wasterlain","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.02.017_bb0620","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.4788-08.2009","article-title":"Subunit-dependent postsynaptic expression of kainate receptors on hippocampal interneurons in area CA1","volume":"29","author":"Wondolowski","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.02.017_bb0625","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0014-4886(91)90042-B","article-title":"Age-related sensitivity to kainate neurotoxicity","volume":"114","author":"Wozniak","year":"1991","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.02.017_bb0630","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.neuroscience.2010.07.055","article-title":"Prenatal ethanol exposure attenuates GABAergic inhibition in basolateral amygdala leading to neuronal hyperexcitability and anxiety-like behavior of adult rat offspring","volume":"170","author":"Zhou","year":"2010","journal-title":"Neuroscience"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119300488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119300488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:15:47Z","timestamp":1760850947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119300488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":126,"alternative-id":["S0969996119300488"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.02.017","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104406"}}